(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
Live Chart Being Loaded With Signals
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system...
Stats | |
---|---|
今日成交量 | 24 483.00 |
平均成交量 | 22 872.00 |
市值 | 21.68M |
EPS | $-0.130 ( 2023-11-13 ) |
下一个收益日期 | ( $0 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.54 |
ATR14 | $0.0150 (0.79%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-05 | Walker Marlan D | Buy | 70 000 | Common Stock |
2023-12-06 | Walker Marlan D | Sell | 14 500 | Common Stock |
2023-12-07 | Walker Marlan D | Sell | 4 550 | Common Stock |
2023-12-05 | Walker Marlan D | Sell | 70 000 | Restricted Stock Units |
2023-11-15 | Rubric Capital Management Lp | Buy | 877 192 | Common Stock, par value $0.001 per share ("Common Stock") |
INSIDER POWER |
---|
77.30 |
Last 94 transactions |
Buy: 1 627 514 | Sell: 264 866 |
TherapeuticsMD Inc 财务报表
Annual | 2023 |
营收: | $1.30M |
毛利润: | $380 000 (29.19 %) |
EPS: | $-0.980 |
FY | 2023 |
营收: | $1.30M |
毛利润: | $380 000 (29.19 %) |
EPS: | $-0.980 |
FY | 2022 |
营收: | $69.96M |
毛利润: | $68.57M (98.00 %) |
EPS: | $-10.35 |
FY | 2021 |
营收: | $86.95M |
毛利润: | $68.11M (78.33 %) |
EPS: | $-0.625 |
Financial Reports:
No articles found.
TherapeuticsMD Inc
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。